People who take Ozempic or Wegovy may have a higher risk of developing a rare form of blindness, a new study suggests. Still, ...
A new study suggests semaglutide, the active ingredient in weight-loss medications Ozempic and Wegovy, may be associated with ...
The popular weight-loss jabs Ozempic and Wegovy have been linked to an eye condition that can cause blindness, according to a new study.People with diabetes prescribed semaglutide (brand names Wegovy ...
Last summer, doctors at Mass Eye and Ear noticed an unusually high number of patients with non-arteritic anterior ischemic ...
Ozempic, Wegovy and other GLP-1 weight-loss drugs appear to increase the risk of a rare and potentially blinding eye ...
GLP-1 medications such as Ozempic and Wegovy may help lower the risk of certain cancers, a new study suggests.
Patients prescribed semaglutide for diabetes or weight loss had a higher risk of having a potentially blinding eye condition, ...
A recent study has suggested that semaglutide drugs like Ozempic and Wegovy are linked to a rare eye condition that can cause ...
People using semaglutide to treat diabetes or lose weight may be at higher risk of developing a condition that causes sudden ...
Those who take Ozempic or Wegovy may have an increased risk of developing a rare form of blindness, though future research is ...
Weight loss drugs may increase the risk of blindness. Study finds a link between semaglutide and NAION, a rare eye condition causing vision loss.